| Overview |
| bsm-0356M-Cy5.5 |
| Digoxin (2E2) Monoclonal Antibody, Cy5.5 Conjugated |
| IF(IHC-P) |
| Others |
| Specifications |
| Cy5.5 |
| Mouse |
| Digoxin-BSA |
| Monoclonal |
| 2E2 |
| IgG |
| 1ug/ul |
| Purified by Protein G. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| Lanoxin. |
| Digoxin is a beta blocker drug originally derived from the foxglove plant, Digitalis lanata. Digoxin is used primarily to improve the pumping ability of the heart in congestive heart failure (CHF), and treat problems such as high blood pressure. It is also used to help normalize some dysrhythmias (abnormal types of heartbeat). |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
Powered by Bioz